Elizabeth Oyekan, PharmD, FCSHP, CPHQ

Pharma Insights

Where Incentives Align (or Don’t) Among Health Care Stakeholders and How They Are Evolving

03/16/2020

The goal of all health care stakeholders—payers, providers, and health systems—is to lower health care costs and improve patient health outcomes, yet the path to getting to this goal remains questionable, partially...

The...

03/16/2020

Journal of Clinical Pathways

Cancer Care in 2021 and Beyond: Catalytic Trends, Entrants, and Developments to Optimize Care During and Post Pandemic

02/22/2021

Elizabeth Oyekan , PharmD, FCSHP, CPHQ;

Health care has been traditionally immune to disruptive market forces until the COVID-19 global pandemic in 2020. This pandemic also highlighted the challenges and failings of our current health care system, creating...

Health...

02/22/2021

Journal of Clinical Pathways

Pharma Insights

Bending the Health Care Cost Curve and Changing the Drug Cost Paradigm in 2021 and Beyond

04/22/2021

Andrew Cournoyer , RPh, MBA;

Elizabeth Oyekan , PharmD, FCSHP, CPHQ;

The continued rise in health care spending continues to have a profound effect on the US economy and health care payers. The three complex drivers contributing to these increases include hospital, outpatient, and...

The...

04/22/2021

Journal of Clinical Pathways

Pharma Insights

Value Transformation: Observations on Performance Periods 1-5 Evaluation Report of the Oncology Care Model

06/21/2021

Elizabeth Oyekan , PharmD, FCSHP, CPHQ;

Maureen Hennessey , PhD, CPCC, CPHQ;

Maureen Hennessey, PhD, CPCC, CPHQ, discusses Medicare spending as well as other performance measures related to the patient experience, management of depression and pain, emergency department and hospital use, end-of-life care, and...

Maureen Hennessey, PhD, CPCC,...

06/21/2021

Journal of Clinical Pathways

Pharma Insights

Impact of NextGen Access Decision Makers on Health Care Services and Therapies

09/23/2021

Elizabeth Oyekan , PharmD, FCSHP, CPHQ;

Dominic Galante , MD, MS, PhD, CPCC;

Elizabeth Oyekan, PharmD, and Dominic Galante, MD, discuss next generation access decision makers and value-based care in the midst of the pandemic and beyond.

Elizabeth Oyekan, PharmD, and...

09/23/2021

Journal of Clinical Pathways

Pharma Insights

The Patient and Consumer Experience—The Core and Progress Duality for Successful and Sustainable Transformation

03/16/2022

Cynthia Miller , MD, MPH, FACP;

Elizabeth Oyekan , PharmD, FCSHP, CPHQ;

Elizabeth Oyekan, PharmD, FCSHP, CPHQ, and colleagues propose a vision for the future of the patient/consumer experience to serve as a blueprint for organizations to develop and implement a strategy that is both effective and in alignment...

Elizabeth Oyekan, PharmD, FCSHP,...

03/16/2022

Journal of Clinical Pathways

Pharma Insights

Big Data Analytics in Health Care and Drug Therapy Management—Opportunities and Considerations

04/20/2022

Elizabeth Oyekan , PharmD, FCSHP, CPHQ;

Marissa Baker-Wagner , MPH;

Ronaé McLin , MPH;

Dr Okeyan and colleagues discuss key areas where big data analytics are being leveraged in health care, the implications to payer and pharma stakeholders, and key considerations for success.

Dr Okeyan and colleagues ...

04/20/2022

Journal of Clinical Pathways

Pharma Insights

Precision Drug Utilization Management: The Future of Oncology Medication Management

06/16/2022

Mark Urban ;

Jeffrey Becker , MBA;

Ronald Schleif , RPh, MBA;

Bruce Edelen ;

Julianna Kula , PharmD, BCOP;

Elizabeth Oyekan , PharmD, FCSHP, CPHQ;

Exponential spending growth in oncology has led to renewed priority to use drug utilization management strategies to help curtail costs without adversely impacting patient care and outcomes and standardizing treatment where appropriate.

Exponential spending growth in...

06/16/2022

Journal of Clinical Pathways

Pharma Insights

Bringing Social Determinants of Health to Life to Optimize Health Outcomes in Patients With Chronic Conditions

02/15/2022

Maureen Hennessey , PhD, CPCC, CPHQ;

Jorge Font , MPH;

Cynthia Miller , MD, MPH, FACP;

Dominic Galante , MD, MS, PhD, CPCC;

Elizabeth Oyekan , PharmD, FCSHP, CPHQ;

Elizabeth Oyekan, PharmD, FCSHP, CPHQ, and colleagues address health care disparities in patients with chronic conditions, the roles of health systems and payers in closing these gaps, and a customizable SDOH toolbox to help stakeholders...

Elizabeth Oyekan, PharmD, FCSHP,...

02/15/2022

Journal of Clinical Pathways